Identification of Challenges to the Availability and Accessibility of Opioids in Twelve European Countries: Conclusions from Two ATOME Six-Country Workshops

Journal of Palliative Medicine

Volumn 18, Issue 12, 2015, Pages 1033-1039

  Linge Dahl, Lisa ^a   Vranken, Marjolein ^b   Juenger, Saskia ^c   North, Kate ^d   Scholten, Willem ^f   Payne, Sheila ^e   Radbruch, Lukas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Help the Hospices   (United Kingdom)

^e LANCASTER UNIVERSITY   (United Kingdom)

^f Independent Pharmaceutical Consultant ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED SUBSTANCE; OPIATE; OPIATE AGONIST; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; AWARENESS; CONTENT ANALYSIS; EUROPEAN; HEALTH CARE ACCESS; HEALTH EDUCATION; HUMAN; PRESCRIPTION; QUESTIONNAIRE; STIGMA; WORKSHOP; ECONOMICS; EUROPE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; LEGISLATION AND JURISPRUDENCE; PAIN; PALLIATIVE THERAPY; REIMBURSEMENT; SUPPLY AND DISTRIBUTION;

ANALGESICS, OPIOID; CONTROLLED SUBSTANCES; EUROPE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; PAIN; PALLIATIVE CARE; REIMBURSEMENT MECHANISMS;

EID: 84949564174     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2015.0051     Document Type: Article

References (27)

1. Pain & Policy Studies Group, University of Wisconsin-Madison; International Narcotics Control Board; United Nations: Opioid Consumption Maps-Morphine Equivalence, mg/capita, 2012. The Board of Regents of the University of Wisconsin System, 2015. ppsg.medicine.wisc .edu/. (Last accessed January 12, 2015).
2. Paudel BD, Ryan KM, Brown MS, et al.: Opioid availability and palliative care in Nepal: Influence of an international pain policy fellowship. J Pain Symptom Manage 2015;49:110-116.
3. Seya MJ, Gelders SFAM, Achara UA, et al.: A First Comparison between the Consumption of and the Need for Opioid Analgesics at Country, Regional and Global Level. J Pain Palliat Care Pharmacother 2011; 25: 6-18.
4. Duthey B, Scholten W: Adequacy of opioid analgesic consumption at country, global and regional level in 2010, its relation to development level and changes compared to 2006. J Pain Symptom Manage 2014;47:283-197.
5. Stoicescu C (ed): Global State of Harm Reduction: Towards an Integrated Response. London, UK: Harm Reduction International, 2012.
6. World Health Organizantion: Ensuring Balance in National Policies on Controlled Substances, Guidance for Availability and Accessibility of Controlled Medicines. Geneva: WHO, 2011.
7. Cleary JF, Hutson P, Joranson D: Access to therapeutic opioid medications in Europe by 2011? Fifty years on from the single convention on narcotic drugs. Palliat Med 2010; 24:109-110.
8. Gilson AM, Maurer MA, Lebaron VT, et al.: Multivariate analysis of countries' government and health-care system influences on opioid availability for cancer pain relief and palliative care: More than a function of human development. Palliat Med 2013;27:105-114.
9. Joranson DE, Ryan KM: Ensuring opioid availability: Methods and resources. J Pain Symptom Manage 2007;33: 527-532.
10. Joranson DE, Ryan KM, Maurer MA: Opioid policy, availability and access in developing and nonindustrialized countries. In: Fishman SM, Ballantyne JC, Rathmell JP (eds): Bonica's Management of Pain, 4th ed. Baltimore, MD: Lippincott Williams & Wilkins, 2010, pp. 194-208.
11. Cherny NI, Catane R, Kosmidis PA: Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering. Ann Oncol 2006;17:885-887.
12. Cherny NI, Baselga J, de Conno F, et al.: Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: A report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 2010;21:615-626.
13. Cherny NI, Cleary J, Scholten W, et al.: The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: Introduction and methodology. Ann Oncol 2013;24:xi7-13.
14. Joranson DE, Ryan KM: Ensuring opioid availability: Methods and resources. J Pain Symptom Manage 2007;33: 527-532.
15. Human Rights Watch: ''Please, do not make us suffer any more:'' Access to Pain Treatment as a Human Right. New York: Human Rights Watch, 2009. www.hrw.org/report/2009/03/03/please-do-not-make-us-suffer-any-more/accesspain-treatment-human-right. (Last accessed July 13, 2015.)
16. Krakauer EL, Wenk R, Buitrago R, et al.: Opioid inaccessibility and its human consequences: Reports from the field. J Pain Palliat Care Pharmacother 2010;24:239-243.
17. Lynch T, Clark D, Centeno C, et al.: Barriers to the development of palliative care in the countries of Central and Eastern Europe and the Commonwealth of Independent States. J Pain Symptom Manage 2009;37:305-315.
18. Lynch T, Clark D, Centeno C, et al.: Barriers to the development of palliative care in Western Europe. Palliat Med 2010;24:812-819.
19. Caraceni A, Hanks G,Kaasa S, et al.: Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:58-68.
20. Ddungu H; African Palliative Care Association: Assuring Availability and Accessibility of Opioid Medicines in the Eastern Mediterranean Region. December 6-8, 2010, Marrakech, Morocco. Workshop report. Kampala, Uganda: African Palliative Care Association, 2011.
21. African Palliative Care Association: Advocacy Workshop for Palliative Care in Africa: A Focus on Essential Pain Medication Accessibility. June 27-29, 2006, Entebbe, Uganda. Workshop report. Kampala, Uganda: African Palliative Care Association, 2011.
22. African Palliative Care Association: Advocacy Workshop for Palliative Care in Africa: A Focus on Essential Pain Medication Accessibility in Southern Africa. February 27-29, 2008, Windhoek, Namibia. Workshop report. Kampala: African Palliative Care Association, 2011.
23. International Association for Hospice & Palliative Care: Message from the Chair and Executive Director: Opioid Availability Workshops. IAHPC newsletter 2011;12. www.hospicecare.com/news/11/04/chair.html. (Last accessed March 30, 2015).
24. Vranken MJ, Mantel-Teeuwisse AK, Junger S, et al.: Legal barriers in accessing opioid medicines: Results of the ATOME quick scan of national legislation of Eastern European countries. J Pain Symptom Manage 2014;48:1135-1144.
25. Vranken M, Lisman J, Mantel A, et al.: Barriers to access to opioid medicines: Results of a review of national legislation and regulations of 11 Central and Eastern European countries. Accepted Lancet Oncology.
26. Radbruch L, Juenger S, Payne S, Scholten W (eds): Access to Opioid Medication in Europe (ATOME): Final Report and Recommendations to the Ministries of Health (English edition). Pallia Med Verlag Bonn, Bonn, Germany, 2014.
27. World Health Organization: Strengthening of Palliative Care as a Component of Integrated Treatment within the Continuum of Care. Geneva: WHO, 2014. apps.who.int/gb/ebwha/pdf-files/EB134/B134-R7-en.pdf. (Last accessedApril 6, 2015.)